Lupin receives approval from USFDA for Ipratropium Bromide Nasal Solution
Peter Bains to replace Jonathan Hunt as CEO of Syngene
NATCO, Lupin receive ANDA approval for Bosentan tablets for oral suspension
Cosmo and Glenmark receives UK MHRA approval to market Winlevi in UK
Wockhardt posts Q3 net profit at Rs. 20 Cr
Briefs: Caplin Point Laboratories, Hikal and Cipla
Jagsonpal Pharmaceuticals appoints Sachin Jain as CFO
NURA AI Health Screening Centre Bengaluru celebrates 4th anniversary of transforming lives through early detection
FDA approves EMBLAVEO for the treatment of adults with complicated intra-abdominal infections
Aurbindo Pharma posts Q3 FY25 profit at Rs. 846 Cr
During the quarter, the company posted Revenue from operations at Rs. 5,269 crore as compared to Rs. 4,505 crore in Q3 FY25, posting a growth of 17 per cent
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes
.jpg)
